Fundraising FoxVIVES Partners — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease.
BiotechHealthtech
Frédéric Marrache(Co-founder & CEO)in
Co-investorsJeito CapitalSanofi VenturesSofinnova PartnersApollo Health VenturesSixty Degree Capital
Generare is building a library of naturally evolved molecules by reading and analyzing biological chemistry that has not been previously studied.
AI & Machine LearningBiotechParis, FR
Co-investorsAgoranovAlvenBetter AngleDaphniGalion.exeTeampact.ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.